Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Plain-English Summary: Prohibiting Tianeptine and Other Dangerous Products Act of 2026

This bill would ban tianeptine, a drug-like substance that is currently sold legally in some U.S. states, often under names like "Tianaa" or "ZaZa," sometimes marketed as a dietary supplement or nootropic. Tianeptine acts on the brain similarly to opioids and has been linked to addiction, withdrawal symptoms, overdoses, and deaths. The bill would classify tianeptine as a controlled or prohibited substance at the federal level, making it illegal to manufacture, sell, or distribute in the United States.

The legislation is also broadly aimed at other dangerous products that may be sold in legal gray areas — such as gas stations, convenience stores, or online retailers — while posing serious health risks. By establishing a federal prohibition, the bill would override the current patchwork of state-by-state rules, where tianeptine is banned in some states but freely available in others.

This bill would most directly affect consumers who currently use tianeptine, retailers and distributors who sell it, and manufacturers who produce it. People who have become dependent on the substance could face challenges accessing it, while sellers would need to remove it from their shelves or face legal consequences. Public health advocates and medical professionals who have raised alarms about tianeptine's risks are among those who have pushed for this type of federal action.

The bill has been referred to the Senate Committee on Health, Education, Labor, and Pensions, where it will be reviewed before any further action is taken.